David S. Ettinger, MD, and Matthew A. Gubens, MD: Immunotherapies for Lung Cancer

Posted: Thursday, March 23, 2017

David S. Ettinger, MD, of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and and Chair of the NCCN Panel on NSCLC, and Matthew A. Gubens, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, discuss NCCN Guidelines updates on non–small cell and small cell lung cancers and the role of biomarker testing in selecting treatment options.